STONEZONE (Roger Stone) - Big Pharma Will Never Help the People
Promising, inexpensive generic drugs may never receive large-scale testing as anti-aging treatments—not because the science is weak, but because the pharmaceutical regulatory system rewards patentable products over affordable public-health solutions. Metformin and rapamycin have shown potential in animal research to influence aging-related biological processes. Yet definitive human trials remain limited. The central obstacle is financial: […] The post Big Pharma Will Never Help the People appeared first on StoneZone .
Promising, inexpensive generic drugs may never receive large-scale testing as anti-aging treatments—not because the science is weak, but because the pharmaceutical regulatory system rewards patentable products over affordable public-health solutions. Metformin and rapamycin have shown potential in animal research to influence aging-related biological processes. Yet definitive human trials remain limited. The central obstacle is financial: rigorous Phase 3 trials can cost hundreds of millions of dollars, while manufacturers have little incentive to fund studies of off-patent drugs that competitors could immediately sell at low prices. That market failure becomes a regulatory failure when government agencies rely primarily on…Open